HOME >> MEDICINE >> NEWS
Drivers with epilepsy are on the road again

As a result of a worldwide cooperative movement, the absolute driving ban for people with epilepsy (PWE) has been lifted in Japan. Since 1960, people who have epilepsy have been banned from driving in Japan. A December article in the journal Epilepsia outlines the efforts and procedures taken to reinstate driving rights to people with epilepsy, a restriction affecting many epilepsy patients throughout the world.

According to experts at Johns Hopkins University, 86 drivers per year died in the U.S. as a result of crashes caused by epileptic seizures between 1995 and 1997. With this potential for accidents and fatalities, laws have been put in place to restrict people who have epilepsy from operating vehicles. Similar restrictions exist for persons with progressive vision loss, for example, reserving the privilege for those who are less likely to have an accident.

A draft of the Road Traffic Act in Japan in December of 2000 stated that people who suffer from epilepsy would not be eligible to receive a driving license at all. After protests from local and international epilepsy organizations and individuals, the Act was revised to allow PWE to obtain a driving license after a seizure-free period of two years.

In order to survey the effect of these new driving regulations, questionnaires were sent to driving authorities and doctors of the Japanese Epilepsy Society (JES). Data showed that some PWE were unwilling to declare their conditions for fear of losing a job, or having their licenses eventually taken away.

"The survey results [further] highlighted the need for cooperation between the driving authorities and JES for further amendment of the regulations as well as the importance of education for the public, patients and professionals," states lead author Yushi Inoue, MD, PhD. These are key factors in efforts to modify restrictions for PWE driving rights worldwide.

According to Dr. Inoue, there are several countries
'"/>

Contact: Sharon Agsalda
medicalnews@bos.blackwellpublishing.net
781-388-8507
Blackwell Publishing Ltd.
23-Dec-2004


Page: 1 2

Related medicine news :

1. Drivers with type-1 diabetes report increased incidence of car crashes
2. New studies show mixed results on epilepsy drugs and birth defects
3. Controversial Atkins Diet may be beneficial for people with epilepsy
4. Early seizures after epilepsy surgery predict more seizures
5. Pacemakers could protect patients with epilepsy from sudden unexplained death
6. Technology points to possible targets for epilepsy and Alzheimers drugs
7. Mayo Clinic finds ketogenic diet may be started as an outpt treatment for children with epilepsy
8. American Academy of Neurology guidelines for treating of epilepsy
9. Monthly hormonal changes can exacerbate seizures in women with epilepsy
10. Patients with uncontrolled epilepsy have low levels of fatty acids
11. Surgery for treatment of temporal lobe epilepsy varies among ethnic groups

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Drivers with epilepsy are the road again

(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... According to ... been developed that changes color when subjected to an impact force that is great ... be implemented in helmets or other sporting equipment so that coaches or officials would ...
(Date:9/4/2015)... ... September 04, 2015 , ... According to an article published August ... Association presented data showing that it is safe for pregnant women to undergo local ... had undergone local anesthesia with a group that hadn’t, researchers were able to determine ...
(Date:9/4/2015)... ... September 04, 2015 , ... On ... has effectively doubled the size of its annual health tech innovation program. Now ... digital health startups to compete for cash and prizes to advance their technologies ...
(Date:9/4/2015)... , ... September 04, 2015 , ... With TransCel from ... mouse all within Final Cut Pro X. With TransCel users have full control over ... width, background color, speed method, frame color, inner color, text, and more. With TransCel ...
(Date:9/4/2015)... ... 2015 , ... Mile High Connects today releases “First and Last Mile Connections,” ... sidewalks, bike paths, and other vital supports severely limit access to public transportation for ... dollars to expand public transit, there’s very little support for safe and convenient access ...
Breaking Medicine News(10 mins):Health News:New Article on Head Injury Detection Technology Highlights Implications for Head Injury Detection in Sports, says The Law Offices of Burg & Brock 2Health News:Recent Study on Dental Care During Pregnancy Demonstrates How Preventative Dental Care Really is for Everyone, Says Medical Center Dental Care 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 3Health News:Pixel Film Studios Releases TransCel, a New FCPX Transition 2Health News:Missed Connections in Metro Denver Transit 2
(Date:9/4/2015)... , Sept. 4, 2015  Janssen Research & ... and Drug Administration (FDA) has accepted for Priority ... as a treatment for patients with multiple myeloma ... (PI) and an immunomodulatory agent (IMiD), or who ... therapy, including a PI and an IMiD. This ...
(Date:9/4/2015)... -- Fair Rate Funding, a lawsuit funding firm located in ... increase in lawsuit filings in connection with the blood thinning ... Philadelphia Court of Common Pleas has ... Louisiana multi---district litigation (MDL), located in ... Louisiana , the filings are also on the ...
(Date:9/4/2015)... HILL, N.C. , Sept. 4, 2015 /PRNewswire/ ... Liaisons (MSLs) and other Field-Based Medical Specialists (FBMS) ... key opinion leaders, and thought leaders in critical ... effectiveness of their field-based teams, companies are expanding ... order to align countries with corporate objectives and ...
Breaking Medicine Technology:U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 2U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 3U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 4U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 5U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 6U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 7Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 2Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 3New Study Presents Tactics and Insights on How to Effectively Globalize Medical Science Liaison Programs in the Pharmaceutical Industry 2
Cached News: